Glucose-6-phosphate dehydrogenase
(G6PDH)
Material: | Activity determination: 2 ml EDTA-blood G6PDH is heat instable. In room temperature (20°C), there is an approximate decrease of 10 % within 24 hours, at 4°C of only 5 % within 3 days. Accordingly, a cooling container (4°C) should be used if shipping of material takes longer. However, EDTA-blood should not be frozen!
Molecular genetic evaluation: 1 – 2 ml EDTA-blood and consent declaration (external services) |
Methods: |
Spektrometrie → UV- / VIS-Photometrie Amplifikationsverfahren → PCR und Sequenzierung | Reference range | 230 – 470 U/1012 erythrocytes (for activity determination) |
Indication | Activity determination: Suspicion of congenital G6PDH-deficiency (favism, X-chromosomal inheritance). Frequency: In central Europe 0,1 %, in European Mediterranean countries 3 – 30 %, Israel up to 60 %, in Africa 30 %, in Eastern Asia about 4 %.
Molecular genetic evaluation: Safe identification of the various G6PDH-variants in case of deficiencies. This may be especially relevant for family planning. |
Comment | Please also refer to: Erythrocyte enzymes |
Please note | G6PDH is heat instable (see above). Therefore, in case of clinical suspicion of G6PD deficiency and longer dispatch timings, a molecular genetic analysis is recommended.
Most people with G6PDH deficiency are symptom-free. There may be various degrees of clinical symptoms. Increased newborn jaundice, hemolytic anemia. In general, only clinically manifest in male descendants (X-chromosomal recessive inheritance). In female heterozygous carriers, there are either no symptoms or symptoms are milder. Hemolytic crisis with upper abdominal problems and lethargy only occur in severe defects and in connection with viral and bacterial infections as well as with the intake of certain drugs and vegetables. |
Accredited | ja |
Please also refer to: | Erythrocyte enzymes |
More Results for the letter G
- Gabapentin (GABA)
- Galactose in the blood (GALA)
- Galactose in the urine (GALAU)
- Galactose-1-phosphate (GAL1)
- Galactose-1-phosphate uridyltransferase (GAL1PU)
- Gal-1-PUT
- Galactosemia-screening (GUTNEO)
- Galactosidase in leucocytes (α-) (GALA06(a))
- Gallstone analysis (GALST)
- Gamma-aminobutyric acid (GAMIN)
- Gamma-GT (GGT)
- GGT, gamma-glutamyl-transpeptidase or -transferase
- Gamma-hydroxy-butyric acid (GHYDRO)
- GHB, liquid ecstasy, knockout drops
- Ganglioside autoantibodies (GANG)
- GQ1b-, GM1-, GM2., GM3-, GD1a-, GD1b-, GT1b-antibodies
- Gardnerella vaginalis (KGARD, GARVAG)
- Gas gangrene (GASBR)
- Clostridium perfringens, novyi, septicum, histolyticum
- Gastrin (GAS)
- Gastrin-producing cells, autoantibodies against (GBZ)
- Gentamicin (GENTA)
- Germanium (GER)
- GLDH (GLDH)
- Glutamate-dehydrogenase
- Gliadin-antibodies (deamidated) IgA and IgG (GLIAS)
- Glomerular basal membrane autoantibodies (GBM)
- GBM antibodies
- Glucagon (GLUK)
- Glucose (GL)
- Plasma glucose
- Glucose metabolism diagnostics (in blood, fasting) (GLUN)
- Glucose metabolism diagnostics (in CSF) (GLUL)
- Glucose-6-phosphate dehydrogenase (GLU6P)
- G6PDH
- Glutamate-decarboxylase autoantibodies (GAD)
- GAD-antibodies
- Glutaric acid (GLUTAR)
- Glutathione (GLUTAT)
- Goblet cells autoantibodies (GOBL)